EGFR expression was verified in several GBM cell lines (GL261, C6, U87 MG, and T98) by quantitative western blot and immunofluorescence to select a targeting cell model and the binding efficacy of C225 to EGFR on U87 MG cells was confirmed. The gene discussed is EGFR; the disease is glioblastoma.